Skip to content

Q Therapeutics, Inc.

CIK 0001366541

← back to feed
Revenue (TTM)
$688.64K
+2,498.9% YoY Q3 Nov 2015
Net Income (TTM)
−$3.19M
+1.1% YoY Q3 Nov 2015
EPS Diluted (TTM)
−$0.84
−365.0% YoY Q3 Nov 2015
Gross Margin
99.2%
Q3 Nov 2015
Operating Margin
-466.5%
Q3 Nov 2015
Net Margin
-463.7%
Q3 Nov 2015
Free Cash Flow (TTM)
−$1.42M
Q3 Nov 2015
Cash
$23.22K
Q3 Nov 2015
Total Debt
—
Q3 Nov 2015
Shares Outstanding
30.83M sh
Q3 Nov 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings